-
【Movie】The micellar nanoparticle technology
| Product | BR | PC | phaseⅠ | phaseⅡ | phaseⅢ |
|---|---|---|---|---|---|
| NC-6004 Cisplatin micelle |
|||||
|
Head and Neck cancer（USA/EU/Taiwan）
Combination therapy with Kyet ruda® |
|||||
| Co-Development Partner：Orient Europharma（Taiwan） |
|||||
| NC-6300 Epirubicin micelle |
|||||
|
Soft tissue sarcoma（USA）
|
|||||
| In-House Development FDA Orphan drug designation |
|||||
| SRN-14/GL2-800 (PRDM14 siRNA) |
|||||
|
HER2-negative breast cancer (Japan)
|
|||||
| Investigator-initiated | |||||
| NK105 Paclitaxel micelle (Out-Licensed) |
|||||
|
Breast cancer（Japan/Asia）
|
|||||
| Out-licensed to Nippon Kayaku（Aria:Japan/Asia） | |||||
| Product | BR | PC | phaseⅠ | phaseⅡ | phaseⅢ | Marketing |
|---|---|---|---|---|---|---|
| VB-111 Non-replicating Adeno 5 vector |
||||||
|
Ovarian cancer（Decided to participate）
|
||||||
| In-House Development In-Licensed from VBL（Aria:Japan） Partner：VBL（Israel） |
||||||
|
Ovarian cancer
|
||||||
| Operation byVBL（USA etc.） | ||||||
|
rGBM
|
||||||
| Investigator-initiated（USA） | ||||||
|
Colorectal Cancer
|
||||||
| Operation by NCI/VBL（USA） | ||||||
| ENT103 ENT product |
||||||
|
Otitis media（Japan）
|
||||||
| Co-Development Partner：CEOLIA PHARMA（Japan） |
||||||
| Aeon Acti-PRP Regenerative medicine |
||||||
|
Intractable infertility PRP therapy（Japan）
|
||||||
| Distributor | ||||||
